• About
• Links
• Contact
• Sitemap

Sitemap > Breaking Research > Diagnostics & Devices

• C-reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure.
• Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma.
• Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors.
• Synthesis and Evaluation of Bivalent NDP-alpha-MSH(7) Peptide Ligands for Binding to the Human Melanocortin Receptor 4 (hMC4R).
• Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample.
• Microfluidic Chips for Detecting the t(4;14) Translocation and Monitoring Disease during Treatment Using Reverse Transcriptase-Polymerase Chain Reaction Analysis of IgH-MMSET Hybrid Transcripts.
• Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1.
• Sirolimus-Eluting Stents in Real-World Patients With ST-Segment Elevation Acute Myocardial Infarction.
• Histone modifications as markers of cancer prognosis: a cellular view.
• An integrated approach to prognosis using protein microarrays and nonparametric methods.
• Rapid detection of enterotoxigenic Staphylococcus aureus harbouring genes for four classical enterotoxins, SEA, SEB, SEC and SED, by loop-mediated isothermal amplification assay.
• A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
• Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions.
• In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
• Development of a Respiratory Virus Panel (RVP) Test for the Detection of Twenty Human Respiratory Viruses using Multiplex PCR and a Fluid Microbead-based Assay.
• MultiCode(R)-PLx System for Multiplexed Detection of Seventeen Respiratory Viruses.
• Anti-norovirus polyclonal antibody and its potential for development of an antigen-ELISA.
• Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.
• An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities.
• Long-Term Clinical Outcomes and Thrombosis Rates of Sirolimus-Eluting Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (REWARDS Registry).
• Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
• Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
• Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal Malignancy.
• Identity Profiling of Cell Surface Markers by Multiplex Gold Nanorod Probes.
• Self-Assembled Hybrid Nanoparticles for Cancer-Specific Multimodal Imaging.
• Selective Immobilization of DNA and Antibody Probes on Electrode Arrays: Simultaneous Electrochemical Detection of DNA and Protein on a Single Platform.
• A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations.
• Extension of the typing in a general-primer-PCR reverse-line-blotting system to detect all 25 cutaneous beta human papillomaviruses.
• Detection of West Nile virus lineages 1 and 2 by real-time PCR.
• Quinazoline derivatives as MC-I inhibitors: Evaluation of myocardial uptake using Positron Emission Tomography in rat and non-human primate.
• Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque.
• Qualitative application of cobas amplicor HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0.
• Cost effectiveness of mammography screening for Chinese women.
• Paclitaxel-eluting composite fibers: Drug release and tensile mechanical properties.
• Performance evaluation of the PROCLEIX(R) West Nile virus assay on semi-automated and automated systems.
• Discovery of N-{(1S,2S)-2-(3-Cyanophenyl)- 3-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a Cannabinoid-1 Receptor Positron Emission Tomography Tracer Suitable for Clinical Use.
• A multiplexed reverse transcriptase PCR assay for identification of viral respiratory pathogens at point-of-care.
• Validation of a Microsphere-Based Immunoassay for Detection of anti-West Nile Virus and anti-St. Louis Encephalitis Virus Immunoglobulin M antibodies.
• Rapid detection and serotyping of dengue virus by multiplex RT-PCR and real-time SYBR green RT-PCR.
• Evaluating the sensitivity of a commercial dengue NS1 antigen-capture ELISA for early diagnosis of acute dengue virus infection.
• Electrical capture and lysis of vaccinia virus particles using silicon nano-scale probe array.
• HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas((R)) TaqScreen MPX test in seroconverting donors.
• Radiohybridization PET Imaging of KRAS G12D mRNA Expression in Human Pancreas Cancer Xenografts with [(64)Cu]DO3A-Peptide Nucleic Acid-Peptide Nanoparticles.
• Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the u.s. Licensed anthrax vaccine.
• Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
• A Method for Reproducibly Preparing Synthetic Nanopores for Resistive-Pulse Biosensors.
• On-Chip Chemiluminescent Signal Enhancement Using Nanostructured Gold-Modified Carbon Microarrays.
• Comparison of infrared-excited up-converting phosphors and europium nanoparticles as labels in a two-site immunoassay.
• Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study.
• Preparation of (99m)Tc-nitrido asymmetrical heterocomplex with 4-(cyclohexylpiperazin-1-yl)-dithioformate and its biological evaluation as a potential myocardial imaging agent.
• Comparison of the Roche COBAS Amplicortrade mark Monitor, Roche COBAS Amplipreptrade mark/COBAS Taqmantrade mark and Abbott RealTimetrade mark Test assays for quantification of hepatitis C virus and HIV RNA.
• Comparison of usability and patient preference for the new disposable insulin device solostar versus flexpen, lilly disposable pen, and a prototype pen: an open-label study.
• Performance characteristics of 65-mer oligonucleotide microarrays.
• High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
• Evaluation of Gene Panel cnRNAs in Urine Samples of Kidney Transplant Recipients as a Non-invasive Tool of Graft Function.
• Nicotinamide N-Methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma.
• Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.
• Myocardial uptake and biodistribution of newly designed technetium-labelled fatty acid analogues.
• Fluorescent antibody test for rapid detection of West Nile virus antigen in avian tissues.
• Developments in Quantitative Oxygen-Saturation Imaging of Breast Tissue In Vivo Using Multispectral Near-Infrared Tomography.
• Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: The TAXi-LATE trial.
• Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
• Preparation and Biologic Evaluation of a Novel Radioiodinated Benzylpiperazine, 123I-MEL037, for Malignant Melanoma.
• Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma.
• Production of Multimeric Prostate-Specific Membrane Antigen Small-Molecule Radiotracers Using a Solid-Phase 99mTc Preloading Strategy.
• In Vivo Evaluation and Small-Animal PET/CT of a Prostate Cancer Mouse Model Using 64Cu Bombesin Analogs: Side-by-Side Comparison of the CB-TE2A and DOTA Chelation Systems.
• In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft.
• Lipid and inflammatory markers for the prediction of coronary artery disease: A multi-marker approach.
• Tumor m2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis.
• Development of real-time PCR assays and evaluation of their potential use for rapid detection of Burkholderia pseudomallei in clinical blood specimens.
• The Binax NOW Test as a Diagnostic Tool for Severe Acute Otitis Media and Associated Complications.
• Multiplex, bead-based suspension array for the molecular determination of common Salmonella serogroups.
• Incidence of ventricular tachyarrhythmias during permanent pacemaker therapy in low-risk patients results from the German multicentre EVENTS study.
• Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
• Fluorescently Labeled Cetuximab to Evaluate Head and Neck Cancer Response to Treatment.
• Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.
• Structure-activity relationship of chalcones and related derivatives as ligands for detecting of beta-amyloid plaques in the brain.
• Plaque Characterization by Virtual Histology Intravascular Ultrasound Analysis in Type II Diabetic Patients.
• Noninvasive Scintigraphic Detection of Tumor with (99m)Tc-DTPA-Deoxyglucose: An Experimental Study.
• Nitinol stenting for treatment of ''below-the-knee'' critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation.
• Peptide-nanoparticle hybrid SERS probes for optical detection of protease activity.
• Large-scale integration of cancer microarray data identifies a robust common cancer signature.
• In vitro discrimination of tumor cell lines with an electronic nose.
• One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
• HPLC for stress-free screening of potential prostate cancer marker catechol estrogens in urine using a diamond-electrode electrochemical and a fluorescence detector.
• Fluorescence detection of bladder cancer using urine cytology.
• In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer (99m)Tc-RAFT-RGD.
• Mammography as screening for coronary artery disease.
• NC100668, A NEW TRACER TESTED FOR IMAGING OF VENOUS THROMBOEMBOLISM: PHARMACOKINETICS AND METABOLISM IN MAN.
• A novel multiplex PCR assay for rapid and simultaneous detection of five pathogenic bacteria: Escherichia coli O157:H7, Salmonella, Staphylococcus aureus, Listeria monocytogenes, and Vibrio parahaemolyticus.
• Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.
• Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.
• Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter.
• Oligonucleotide chip, real-time PCR and sequencing for genotyping of hepatitis B virus.
• Synthesis and Biological Evaluation of the Mitochondrial Complex 1 Inhibitor 2-[4-(4-Fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one as a Potential Cardiac Positron Emission Tomography Tracer.
• Quality of Life After Balloon Angioplasty Versus Stent Implantation in the Superficial Femoral Artery: Findings from a Randomized Controlled Trial.
• Treatment of Critical Limb Ischemia Using Ultrasound-enhanced Thrombolysis (PARES Trial): Final Results.
• Subintimal Angioplasty of Infrainguinal Arterial Occlusions for Critical Limb Ischemia: Long-term Patency and Clinical Efficacy.
• Biomarker discovery for colon cancer using a 761 gene RT-PCR assay.
• Use of a Peptide Derived from Foot-and-Mouth Disease Virus for the Noninvasive Imaging of Human Cancer: Generation and Evaluation of 4-[18F]Fluorobenzoyl A20FMDV2 for In vivo Imaging of Integrin {alpha}v{beta}6 Expression with Positron Emission Tomography.
• Role of 99mTc-Octreotide Acetate Scintigraphy in Suspected Lung Cancer Compared with 18F-FDG Dual-Head Coincidence Imaging.
• microPET of Tumor Integrin {alpha}v{beta}3 Expression Using 18F-Labeled PEGylated Tetrameric RGD Peptide (18F-FPRGD4).
• Prediction of Atherosclerotic Plaque Ruptures with High Frequency Ultrasound Imaging and Serum Inflammatory Markers.
• Development and evaluation of a real-time PCR assay for rapid identification and semi-quantitation of measles virus.
• Styryl-Based Compounds as Potential in vivo Imaging Agents for beta-Amyloid Plaques.
• Synthesis and in Vivo Evaluation of Fluorine-18 and Iodine-123 Labeled 2beta-Carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a Candidate Serotonin Transporter Imaging Agent.
• The Medtronic MiniMed Gold Continuous Glucose Monitoring System: An Effective Means to Discover Hypo- and Hyperglycemia in Children Under 7 Years of Age.
• Synthesis, transportability and hypoxiaselective binding of 1-beta-D-(5-Deoxy-5-fluororibofuranosyl)-2-nitroimidazole (beta-5-FAZR), a configurational isomer of the clinical hypoxia marker, FAZA.
• Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study.
• Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
• Comparison of the Abbott Architect i2000 Assay, the Roche Modular Analytics E170 Assay, and an Immunoradiometric Assay for Serum Hepatitis B Virus Markers.
• Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study.
• A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
• Ultrasensitive Detection of Enzymatic Activity with Nanowire Electrodes.
• The Optimization of Magnetosandwich Assays for the Sensitive and Specific Detection of Proteins in Serum.
• Assessment of the IgG index in dogs by indirect immunoenzimatic assays as diagnostic tool for inflammatory diseases of central nervous system.
• Analytical validation of commercial immunoassays for the measurement of cardiovascular peptides in the dog.
• Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
• Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor.
• Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients.
• [11C]Vinblastine syntheses and preliminary imaging in cancer patients.
• (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
• Comparison of the Dako EGFR pharmDx Kit and Zymed EGFR Antibody for Assessment of EGFR Status in Colorectal Adenocarcinoma.
• PGDS, A Novel Technique Combining Chromogenic In Situ Hybridization and Immunohistochemistry for the Assessment of ErbB2 (HER2/neu) Status in Breast Cancer.
• Use of the Real-time PCR Assay in Conjunction With MagNA Pure for the Detection of Mycobacterial DNA From Fixed Specimens.
• RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping.
• N-Benzyl-2-(6,8-dichloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-N-(6- (7-nitrobenzo[c][1,2,5]oxadiazol-4-ylamino)hexyl)acetamide as a New Fluorescent Probe for Peripheral Benzodiazepine Receptor and Microglial Cell Visualization.
• Synthesis and Structure-Affinity Relationships of New 4-(6-Iodo-H-imidazo[1,2-a]pyridin-2-yl)-N-dimethylbenzeneamine Derivatives as Ligands for Human beta-Amyloid Plaques.
• Porous silicon biosensor for detection of viruses.
• Design, Synthesis, and Characterization of a Dual Modality Positron Emission Tomography and Fluorescence Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging.
• PERFORMANCE OF A PNEUMOLYSIN ELISA ASSAY FOR THE DIAGNOSIS OF PNEUMOCOCCAL INFECTIONS.
• Breast-specific gamma imaging with (99m)tc-sestamibi and magnetic resonance imaging in the diagnosis of breast cancer-a comparative study.
• DNA Stool Test for Colorectal Cancer: Hypermethylation of the Secreted Frizzled-Related Protein-1 Gene.
• Diagnostic performance of a rapid antigen test for RSV in comparison with a 19-valent multiplex RT-PCR ELISA in children with acute respiratory tract infections.
• Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
• Conducting polymer based fluorescence quenching as a new approach to increase the selectivity of immunosensors.
• Real time contrast enhanced ultrasonography (CEUS) in detection of liver metastases from gastrointestinal cancer.
• Anti-Cardiolipin and Anti-beta2-Glycoprotein I Antibodies: Performance of New Commercial ELISA Kits.
• Tumor Imaging Using 1-(2'-deoxy-2'-18F- Fluoro-{beta}-D-Arabinofuranosyl)Thymine and PET.
• Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
• Preclinical and Clinical Studies With the Multi-Kinase Inhibitor CEP-701 as Treatment for Prostate Cancer Demonstrate the Inadequacy of PSA Response as a Primary Endpoint.
• Comparison of Aminolevulinic Acid- and Hexylester Aminolevulinate-Induced Protoporphyrin IX Fluorescence for the Detection of Ovarian Cancer in a Rat Model.
• Evidence of Specificity of Radiolabeled Phage Display Peptides for the TAG-72 Antigen.
• Cytotoxicity of the novel spin trapping compound 5-ethoxycarbonyl-3,5-dimethyl-pyrroline N-oxide (3,5-EDPO) and its derivatives.
• Rapid multiplex nested-PCR for detection of respiratory viruses.
• Highly sensitive and broadly reactive quantitative RT-PCR assay for high throughput detection of Rift Valley fever virus.
• Clostridium perfringens Enterotoxin as a Novel-Targeted Therapeutic for Brain Metastasis.
• Dendrimer-Modified Magnetic Nanoparticles Enhance Efficiency of Gene Delivery System.
• Radiofrequency ablation for hepatocellular carcinoma: a prospective comparison of four radiofrequency devices.
• Evaluation of [(11)C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
• Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan((R)) and Primer-Probe Energy Transfer.
• Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States.
• International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
• Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience.
• Novel chalcones as probes for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
• Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis.
• Development of a TaqMan(R) Minor Groove Binding Protein Assay for the Detection and Quantification of Crimean-Congo Hemorrhagic Fever Virus.
• Antirestenotic Effects of a Novel Polymer-Coated D-24851 Eluting Stent. Experimental Data in a Rabbit Iliac Artery Model.
• Polyfluorinated Bis-styrylbenzene beta-Amyloid Plaque Binding Ligands.
• The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.
• In vivo amyloid imaging with PET in frontotemporal dementia.
• R2 and R2* Mapping for Sensing Cell-bound Superparamagnetic Nanoparticles: In Vitro and Murine in Vivo Testing.
• Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA).
• 4-[omega-[4-Arylpiperazin-1-yl]alkoxy]phenyl)imidazo[1,2-a]pyridine Derivatives: Fluorescent High-Affinity Dopamine D(3) Receptor Ligands as Potential Probes for Receptor Visualization.
• A cytokine immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy.
• MDR1 Single Nucleotide Polymorphisms Predict Response to Vinorelbine-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer.
• Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer.
• [(11)C]-PIB imaging in patients with Parkinson's disease: Preliminary results.
• An Aminoglycoside Microarray Platform for Directly Monitoring and Studying Antibiotic Resistance.
• The anti-inflammatory mechanism of 635 nm light-emitting-diode irradiation compared with existing COX inhibitors.
• Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
• Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer.
• Surrogate End Points for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis From 39 Randomized Controlled Trials of First-Line Chemotherapy.
• Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers.
• Improved rate of high-grade cervical intraepithelial neoplasia detection in human papillomavirus DNA hybrid capture testing.
• Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients.
• Evaluation of the pharmacokinetics of All-Trans-Retinoic Acid (ATRA) in wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines.
• Safety of carotid artery stenting for symptomatic carotid artery disease: a meta-analysis.
• PRELIMINARY EVALUATION OF A MULTIPLEX RT-PCR COMBINED WITH A NEW DNA-CHIP HYBRIDIZATION FOR DETECTING RESPIRATORY SYNCYTIAL VIRUS.
• Diffusion-Weighted and Macromolecular Contrast Enhanced MRI of Tumor Response to Antivascular Therapy with ZD6126.
• Combined [(18)F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Detection of Recurrent, (131)I-Negative Thyroid Cancer.
• Cell Cycle Regulators Show Diagnostic and Prognostic Utility for Differentiated Thyroid Cancer.
• Cancer Diagnosis by Discrimination between Normal and Malignant Human Blood Samples Using Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy.
• Comparison of Triple Versus Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation (from the DECLARE-Long Trial).
• Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging.
• Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MRI.
• Green and Orange CdTe Quantum Dots as Effective pH-Sensitive Fluorescent Probes for Dual Simultaneous and Independent Detection of Viruses.
• Susceptibility Contrast Magnetic Resonance Imaging Determination of Fractional Tumor Blood Volume: A Noninvasive Imaging Biomarker of Response to the Vascular Disrupting Agent ZD6126.
• In vitro characterization of the Gd complex of [2,6-pyridinediylbis(methylene nitrilo)] tetraacetic acid (PMN-tetraacetic acid) and of its Eu analogue, suitable bimodal contrast agents for MRI and optical imaging.
• Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases.
• Synthesis of Tc-99m labeled glucosamino-Asp-cyclic(Arg-Gly-Asp-d-Phe-Lys) as a potential angiogenesis imaging agent.
• Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer.
• In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide.
• Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles: Synthesis and Application as a Dual Imaging Probe for Cancer in Vivo.
• Progensa PCA3 test for prostate cancer detection.
• Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: A pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens.
• Lung Deposition of Formoterol HFA (Atimos((R))/Forair((R))) in Healthy Volunteers, Asthmatic and COPD Patients.
• Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology.
• Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer.
• Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers.
• Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines.
• Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia.
• Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model.
• Tumor imaging using technetium-99m bound to pH-sensitive peptides.
• Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke. A Systematic Review.
• Lab-on-a-chip for oral cancer screening and diagnosis.
• Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
• Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction.
• A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
• Synthesis and evaluation of a (99m)Tc-BAT-phenylbenzothiazole conjugate as a potential in vivo tracer for visualization of amyloid beta.
• Detection of pim-1 mRNA in prostate cancer diagnosis.
• Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.
• A human papillomavirus testing system in women with abnormal Pap results: a comparison study with follow-up biopsies.
• Rapid isothermal detection assay: a probe amplification method for the detection of nucleic acids.
• In vivo Radioiodide Imaging and Treatment of Pancreatic Cancer Xenografts after MUC1 Promoter-Driven Expression of the Human Sodium-Iodide Symporter.
• Paclitaxel-eluting stent Taxcor: first application in man.
• Novel Decapeptides that Bind Avidly and Deliver Radioisotope to Colon Cancer Cells.
• Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence.
• Promising Antitumor Activity of a Novel Quinoline Derivative, TAS-103, against Fresh Clinical Specimens of Eight Types of Tumors Measured by Flow Cytometric DNA Analysis.
• Cancer Imaging With Fluorine-18-Labeled Choline Derivatives.
• FLT: Measuring Tumor Cell Proliferation In Vivo With Positron Emission Tomography and 3'-Deoxy-3'-[(18)F]Fluorothymidine.
• Imaging multidrug resistance with 4-[(18)F]fluoropaclitaxel.
• Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer.
• Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design.
• High-resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
• Part II: Inhaler technique and adherence to therapy.
• Magnetic Bead Sensing Platform for the Detection of Proteins.
• Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection.
• Evaluation of a Multiplexed PCR Assay for Detection of Respiratory Viral Pathogens in a Public Health Laboratory Setting.
• Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: Six-month results of the ETHOS I trial.
• Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment.
• Cost-effectiveness of primary cytology and HPV DNA cervical screening.
• Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
• Specific MALDI Imaging and Profiling for Biomarker Hunting and Validation: Fragment of the 11S Proteasome Activator Complex, Reg Alpha Fragment, Is a New Potential Ovary Cancer Biomarker.
• Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus.
• Evaluation of a new ultrasensitive assay for cardiac troponin I.
• A novel drug-eluting stent using bioabsorbable polymer technology: Two-year follow-up of the CURAMI registry.
• CHARACTERISATION OF A NEW SENSITIVE PCR ASSAY FOR THE QUANTIFICATION OF VIRAL DNA ISOLATED FROM PATIENTS WITH HEPATITIS B INFECTIONS.
• Hepatitis B Virus Core-related Antigens as a Marker for Monitoring of Chronic Hepatitis B Infection.
• Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature.
• Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
• Evaluation of an 111In-Radiolabeled Peptide as a Targeting and Imaging Agent for ErbB-2 Receptor Expressing Breast Carcinomas.
• Pharmacogenomic Predictor Discovery in Phase II Clinical Trials for Breast Cancer.
• Prostate cancer detection rate of transrectal ultrasonography, digital rectal examination, and prostate-specific antigen: results of a five-year study of 6- versus 12-core transperineal prostate biopsy.
• Polymer Microfluidic Chips with Integrated Waveguides for Reading Microarrays.
• The PREDICT (residual platelet aggregation after deployment of intracoronary stent)-score.
• One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.
• Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting.
• Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.
• Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study.
• Evaluation of the available anti-HCV antibody Detection Tests and RT-PCR assay in the Diagnosis of Hepatitis C Virus Infection.
• Estimation of Apparent Tumor Vascular Permeability from Multiphoton Fluorescence Microscopic Images of P22 Rat Sarcomas In Vivo.
• American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer.
• Trends in HIV testing and differences between planned and actual testing in the United States, 2000-2005.
• Acute Experimental Study of Abiomed BVS5000 as a V-A Bypass to Cardiogenic Shock Models.
• Novel Fluorinated Derivatives of the Broad-Spectrum MMP Inhibitors N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as Potential Tools for the Molecular Imaging of Activated MMPs with PET.
• Artificial Neural Network Study of Whole-Cell Bacterial Bioreporter Response Determined Using Fluorescence Flow Cytometry.
• Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers.
• Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals.
• DETECTION OF HIGH RISK PAPILLOMAVIRUS DNA WITH COMMERCIAL INVADER(R) TECHNOLOGY-BASED ANALYTE SPECIFIC REAGENTS FOLLOWING AUTOMATED EXTRACTION OF DNA FROM CERVICAL BRUSHINGS IN THINPREPTM MEDIA.
• Novel LUXTM Real-time PCR Assays for Detection and Quantification of Genogroups I and II Noroviruses in Clinical Specimens.
• Potential effects of decreased cervical cancer screening participation after HPV vaccination: An example from the U.S.
• Chemotherapy response evaluation with FDG PET in patients with colorectal cancer.
• Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.
• Multidetector row computed tomography can identify and characterize the occlusive culprit lesions in patients early (within 24 hours) after acute myocardial infarction.
• 7,528 Patients Treated with PCI - A Scandinavian Real-Life Scenario.
• Colorimetric / fluorescent bacterial sensing by agarose-embedded lipid / polydiacetylene films.
• Self-monitoring of blood glucose among adults with diabetes--United States, 1997-2006.
• Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase.
• Development of a novel hot-start multiplex PCR for simultaneous detection of classical swine fever virus, African swine fever virus, porcine circovirus type 2, porcine reproductive and respiratory syndrome virus and porcine parvovirus.
• Gold nanocages for cancer detection and treatment.
• SERS nanoparticles: a new optical detection modality for cancer diagnosis.
• Radioiodination of mouse anti-III beta-tubulin antibodies and their evaluation with respect to their use as diagnostic agents for peripheral neuropathies.
• Comparison of four commercial screening assays for the diagnosis of human T-cell Lymphotropic virus types 1 and 2.
• Gene-expression microarrays provide new prognostic and predictive tests for breast cancer.
• A novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues.
• Synthesis of (131)I-Labeled-[(131)I]Iodo-17-Allylamino-17-Demethoxy Geldanamycin ([(131)I]Iodo-17-AAG) and Its Biodistribution in Mice.
• FCER2: A pharmacogenetic basis for severe exacerbations in children with asthma.
• Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study.
• Detection of single-nucleotide polymorphisms in cancer-related genes by minisequencing on a microelectronic DNA chip.
• Diagnostic criteria patterns of U.S. children with Metabolic Syndrome: NHANES 1999-2002.
• BlotGlycoABCTM: An integrated glycoblotting technique for rapid and large-scale clinical glycomics.
• Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costs.
• Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies.
• Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
• Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8.
• Pharmacokinetics of 3-[(125)I]iodo-alpha-methyl-l-tyrosine, a tumor imaging agent, after probenecid loading in mice implanted with colon cancer DLD-1 cells.
• Rapid, Sensitive and Specific Lateral-Flow Immunochromatographic Point-of-Care Device to Detect HSV-2 Specific Immunoglobulin G Antibodies in Serum and Whole Blood.
• Specific reactivity of mild/severe Alzheimer's disease patient's sera to antibody against Abeta1-40 epitope 17-21.
• Bacterial characterization using protein profiling in a microchip separations platform.
• A micropillar-integrated smart microfluidic device for specific capture and sorting of cells.
• Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.
• Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.
• Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: A novel PET myocardial imaging agent.
• BMS-747158-02: A novel PET myocardial perfusion imaging agent.
• N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.
• Use of AngioJet mechanical thrombectomy for acute peripheral ischemia associated with stent fracture.
• Osteopontin as a molecular prognostic marker for melanoma.
• Lower Limb Revascularization with a New Bioactive Prosthetic Graft: Early and Late Results.
• Improved synthesis of no-carrier-added p-[(124)I]iodo-l-phenylalanine and p-[(131)I]iodo-l-phenylalanine for nuclear medicine applications in malignant gliomas.
• Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases.
• Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer.
• Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
• Label-Free DNA Detection of Hepatitis C Virus Based on Modified Conducting Polypyrrole Films at Microelectrodes and Atomic Force Microscopy Tip-Integrated Electrodes.
• Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays.
• Diagnostic and prognostic significance of gene expression profiling in lymphomas.
• Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.
• Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina.
• Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina.
• Results of the multicenter first-in-man study of a novel scoring balloon catheter for the treatment of infra-popliteal peripheral arterial disease.
• Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
• Synthesis of new carbon-11 labeled benzoxazole derivatives for PET imaging of 5-HT(3) receptor.
• Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling.
• High throughput analysis of breast cancer specimens on the grid.
• Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock.
• 2-(2'-((Dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine Derivatives as Serotonin Transporter Imaging Agents.
• Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report.
• Rapid lab-on-a-chip profiling of human gut bacteria.
• Telomere DNA content predicts breast cancer free survival interval.
• Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer.
• GRO-{alpha}: A Potential Marker for Cancer and Aging Silenced by RNA Interference.
• Real-time RT-PCR Assay for Comprehensive Detection of Human Rhinoviruses.
• Evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([(18)F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [ (18)F]-D: -FMAU and [ (18)F]FLT.
• Macrophage migration inhibitory factor in cancer.
• CD200: A putative therapeutic target in cancer.
• Salivary mRNA targets for cancer diagnostics.
• A multicenter evaluation of the PCA3 molecular urine test: Pre-analytical effects, analytical performance, and diagnostic accuracy.
• The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method.
• Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer.
• Sensitivity of a rapid immuno-chromatographic test for Hepatitis C antibodies detection.
• Early diagnosis and prediction of severity in acute pancreatitis using the urine trypsinogen-2 dipstick test: A prospective study.
• S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
• Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells.
• A Rapid Sample Pretreatment Protocol: Improved Sensitivity in the Detection of a Low-abundant Serum Biomarker for Prostate Cancer.
• Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers.
• Predicting response and resistance to endocrine therapy : profiling patients on aromatase inhibitors.
• Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: Implications for predictive testing.
• Procalcitonin as a diagnostic aid in diabetic foot infections.
• Elevated serum C-reactive protein levels as a predictive indicator for subsequent renal impairment in patients with acute heart failure.
• Diagnostic and Prognostic Utility of t(14;18) in Follicular Lymphoma.
• Controlled Internalization of Her-2/neu Receptors by Cross-linking for Targeted Delivery.
• SEPT9_V1 Protein Expression is Associated with Human Cancer Cell Resistance to Microtubule Disrupting Agents.
• Relationship between Leptin Concentration and Insulin Resistance.
• Aurora kinase inhibitors: identification and preclinical validation of their biomarkers.
• Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting.
• PET Imaging of VPAC1 Expression in Experimental and Spontaneous Prostate Cancer.
• Comparison of Integrin {alpha}v{beta}3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDG.
• Synthesis and Evaluation of N-Methyl and S-Methyl (11)C-Labeled 6-Methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as Radioligands for Imaging beta-Amyloid Plaques in Alzheimer's Disease.
• A highly sensitive and versatile virus titration assay in the 96-well microplate format.
• Contribution of a Single Repeat PSA Test to Prostate Cancer Risk Assessment: Experience from the ProtecT Study.
• Psychometric properties of the Beck Depression Inventory-Second Edition (BDI-II) in individuals with chronic pain.
• Establishment of hybrid cell lines producing monoclonal antibodies to a synthetic Peptide from the e1 region of the hepatitis C virus.
• Rapid and simple detection of a mycobacterium circulating antigen in serum of pulmonary tuberculosis patients by using a monoclonal antibody and Fast-Dot-ELISA.
• Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report.
• Use of a SQUID array to detect T-cells with magnetic nanoparticles in determining transplant rejection.
• A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. I. In vitro/in vivo stability of the scaffold and in vitro sensitivity of the glucose sensor with scaffold.
• Diagnostic Accuracy Study of Urine Dipstick in Relation to 24-Hour Measurement as a Screening Tool for Proteinuria in Lupus Nephritis.
• Glycopolydiacetylene nanoparticles as a chromatic biosensor to detect Shiga-like toxin producing Escherichia coli O157:H7.
• Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention.
• Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival.
• Direct acoustic profiling of DNA hybridisation using HSV type 1 viral sequences.
• Enzyme-catalyzed signal amplification for electrochemical DNA detection with a PNA-modified electrode.
• Predicting patients at high-risk of systemic reactions to cluster allergen immunotherapy: a pilot prospective observational study.
• Semi-mechanistic description of the in-vitro antiproliferative effect of different antitumour agents.
• Pretransplant Donor-Specific Interferon-gamma ELISPOT Assay Predicts Acute Rejection Episodes in Renal Transplant Recipients.
• Could BNP screening of acute chest pain cases lead to safe earlier discharge of patients with non-cardiac causes? A pilot study.
• Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
• The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery.
• NQO1 Expression in Pancreatic Cancer and Its Potential Use as a Biomarker.
• Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma.
• In vivo bioluminescence visualization of antitumor effects by human MUC1 vaccination.
• Detection of non-ST-elevation myocardial infarction and unstable angina in the acute setting: meta-analysis of diagnostic performance of multi- detector domputed tomographic angiography.
• Multiplex real-time PCR for detection of respiratory tract infections.
• The eap Gene as a Novel Target for Specific Identification of Staphylococcus aureus.
• An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation.
• A Differential Diagnostic Model of Diabetic Nephropathy and Non-Diabetic Renal Diseases.
• Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis.
• Role of FDG-PET in the Assessment of Survival Prognosis in Melanoma.
• Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.
• (R)-N-Methyl-3-(3-(125)I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters.
• Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer.
• Feasibility studies of 4'-[methyl-(11)C]thiothymidine as a tumor proliferation imaging agent in mice.
• Comparison of VERSANT Hepatitis B Virus DNA 3.0 Assay with Digene Hybrid Capture II Hepatitis B Virus DNA Test in Relation to Clinical Status of Hepatitis B Virus.
• Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma.
• Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer.
• Cost-effectiveness of digital mammography breast cancer screening.
• MicroRNA Signature Predicts Survival and Relapse in Lung Cancer.
• Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
• Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver.
• Transcriptome profile of human colorectal adenomas.
• Self-Monitoring of Blood Glucose Before and After Medicare Expansion Among Medicare Beneficiaries With Diabetes Who Do Not Use Insulin.
• CHEK*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls.
• Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
• Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects.
• Prostate-Specific Antigen Screening and Mortality from Prostate Cancer.
• Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
• Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
• The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
• Molecular imaging of {alpha}v 3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.
• Human Papillomavirus in Atypical Squamous Cervical Cytology: The Invader HPV Test as a New Screening Assay.
• Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
• The ChemoFx(R) Assay: An Ex Vivo Chemosensitivity and Resistance Assay for Predicting Patient Response to Cancer Chemotherapy.
• Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes.
• Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: A semiquantitative study of immunoreactivities using tissue array.
• Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation.
• Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
• The Human Combinatorial Antibody Library HuCAL GOLD Combines Diversification of All Six CDRs According to the Natural Immune System with a Novel Display Method for Efficient Selection of High-Affinity Antibodies.
• Imaging of amyloid beta in Alzheimer's disease with (18)F-BAY94-9172, a novel PET tracer: proof of mechanism.
• Clinical efficacy and patient satisfaction with U-500 insulin pump therapy in patients with type 2 diabetes.
• Does Renin-Angiotensin Aldosterone System Blockade Exacerbate Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease? A Prospective 50-month Mayo Clinic Study.
• (111)In-Labeled Lactam Bridge-Cyclized alpha-Melanocyte Stimulating Hormone Peptide Analogues for Melanoma Imaging.
• Assessment of bevacizumab conjugated to cy5.5 for detection of head and neck cancer xenografts.
• Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting.
• A Multicenter Clinical Trial on the Diagnostic Value of Dual-Tracer PET/CT in Pulmonary Lesions Using 3'-Deoxy-3'-18F-Fluorothymidine and 18F-FDG.
• Development of an immunochromatographic strip for rapid detection of the H9 subtype of avian influenza viruses (H9AIVs).
• Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects.
• Selection of a novel drug-response predictor in esophageal cancer: A novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.
• Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: Diagnostic and prognostic implications.
• Novel Blood-Based, Five-Gene Biomarker Set for the Detection of Colorectal Cancer.
• Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies.
• Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.
• Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines.
• Expression of alpha(1)-Adrenoceptor Subtype mRNA as a Predictor of the Efficacy of Subtype Selective alpha(1)-Adrenoceptor Antagonists in the Management of Benign Prostatic Hyperplasia.
• Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastases in Patients With Breast Cancer.
• Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
• Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy.
• Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.
• Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection.
• Development and validation of a predictive model for chemotherapy-associated thrombosis.
• Development of Homogeneous 384-Well High-Throughput Screening Assays for A{beta}1-40 and A{beta}1-42 Using AlphaScreenTM Technology.
• Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator).
• Use of CoZmonitor((R)) in youth with type 1 diabetes.
• Synthesis and evaluation of stilbenylbenzoxazole and stilbenylbenzothiazole derivatives for detecting beta-amyloid fibrils.
• Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
• Breast cancer mortality with varying invitational policies in organised mammography.
• Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome.
• Efficacy of automatic mode switching in DDDR mode pacemakers: The most 2 study.
• Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis.
• Comparison of p16(INK4A) and Hybrid Capture(R) 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePathtrade mark preparations.
• Effectiveness of sputum cytology using ThinPrep(R) method for evaluation of lung cancer.
• Development and studies of the anti-R7V neutralizing antibody ELISA test: A new serological test for HIV seropositive patients.
• Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis.
• Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
• Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infection.
• Tumor markers in staging and prognosis of colorectal carcinoma.
• Factors Associated With Off-Label Use of Drug-Eluting Stents in Patients With ST-Elevation Myocardial Infarction.
• Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
• The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention insights from a large regional registry of contemporary percutaneous coronary intervention.
• Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.
• Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis.
• Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial.
• Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
• Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival.
• MALDI Imaging of Formalin-Fixed Paraffin-Embedded Tissues: Application to Model Animals of Parkinson Disease for Biomarker Hunting.
• A novel microfluidic biosensor based on an electrical detection system for alpha-fetoprotein.
• Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions.
• Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia.
• Use of a Panel of Novel Genes for Differentiating Breast Cancer from Non-Breast Tissues.
• Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.
• Labeling of Adenovirus Particles with PARACEST Agents.
• Assessment of {alpha}v{beta}3Integrin Expression after Myocarcdial Infarction by Positron Emission Tomography.
• RespiFinder: a new multiparameter test to differentially identify 15 respiratory viruses.
• ENSAM: Europium Nanoparticles for Signal Enhancement of Antibody Microarrays on Nanoporous Silicon.
• Synthesis and evaluation of [(123)I] labeled iodovinyl amino acids syn-, anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid, and 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid as potential SPECT brain tumor imaging agents.
• Diagnostic Markers for Early Detection of Ovarian Cancer.
• 1,3-beta-d-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia.
• Automated detection of diabetic retinopathy: results of a screening study.
• "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.
• Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections.
• Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study.
• Validation of the 7-Minute Screen for the Detection of Early-Stage Alzheimer's Disease.
• Induction of ErbB-3 Expression by alpha6beta4 Integrin Contributes to Tamoxifen Resistance in ERbeta1-Negative Breast Carcinomas.
• Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
• A New Immuno-PCR Assay for the Detection of Low Concentrations of Shiga Toxin 2 and Its Variants.
• HER-2/neu expression in primary and metastatic breast cancer.
• CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
• PB183, a sigma receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma.
• Performance Characteristics of a Quantitative Hepatitis C Virus RNA Assay Using COBAS AmpliPrep Total Nucleic Acid Isolation and COBAS TaqMan Hepatitis C Virus Analyte-Specific Reagent.
• Evaluation of the Branched-Chain DNA Assay for Measurement of RNA in Formalin-Fixed Tissues.
• Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis.
• A Comprehensive Approach Toward Novel Serum Biomarkers for Benign Prostatic Hyperplasia: The MPSA Consortium.
• N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
• Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
• TREK-1 is a novel molecular target in prostate cancer.
• Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
• Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas.
• Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb(R)) in human breast carcinoma cells.
• Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening.
• Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403).
• Generation of Affibody ligands binding the IL-2 receptor alpha.
• Phosphorylated STAT5 Represents a New Possible Prognostic Marker in Hodgkin Lymphoma.
• Interleukin-6 Is a Better Predictor of Mortality as Compared to C-Reactive Protein, Homocysteine, Pentosidine and Advanced Oxidation Protein Products in Hemodialysis Patients.
• Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
• Predictive value of Ki67 and p53 in locally advanced rectal cancer: Correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
• Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation.
• Repeat thrombolysis or conservative therapy vs. rescue percutaneous coronary intervention for failed thrombolysis: systematic review and meta-analysis.
• Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis.
• Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis.
• Folate-Conjugated Thermoresponsive Block Copolymers: Highly Efficient Conjugation and Solution Self-Assembly.
• Tumor-specific nano-entities for optical detection and hyperthermic treatment of breast cancer.
• Immunoassays in Nanoliter Volume Reactors Using Fluorescent Particle Diffusometry.
• A comparison of three real-time PCR assays for the confirmation of Neisseria gonorrhoeae following detection of N. gonorrhoeae using Roche COBAS AMPLICOR.
• Post-myocardial infarction beta-blocker therapy: The bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
• Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-a randomized controlled study.
• Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
• Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.
• Greater availability of dopamine transporters in patients with major depression - A dual-isotope SPECT study.
• Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury.
• Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'
• Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCELtrade mark), a multi-targeted kinase inhibitor.
• Bioluminescence-Based Detection of MicroRNA, miR21 in Breast Cancer Cells.
• A Serum Biomarker Profile Associated with High Bone Turnover and Bone Mineral Density in Postmenopausal Women.
• Assessment of RT-PCR Detection of Human Mammaglobin for the Diagnosis of Breast Cancer Derived Pleural Effusions.
• Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathway.
• Merging microarray data from separate breast cancer studies provides a robust prognostic test.
• Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.
• Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease.
• Novel prodrugs for targeting diagnostic and therapeutic radionuclides to solid tumors.
• [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma.
• Synthesis, Radiofluorination, and In Vitro Evaluation of Pyrazolo[1,5-a]pyridine-Based Dopamine D4 Receptor Ligands: Discovery of an Inverse Agonist Radioligand for PET.
• Breast cancer subtypes and survival in patients with brain metastases.
• Prediction of Alzheimer's Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated beta-Amyloid Peptides.
• The Effects of Fluticasone With or Without Salmeterol On Systemic Biomarkers of Inflammation in COPD.
• Humoral Immunity Directed against Tumor-Associated Antigens As Potential Biomarkers for the Early Diagnosis of Cancer.
• Application of Protein Microarrays for Multiplexed Detection of Antibodies to Tumor Antigens in Breast Cancer.
• Plasma Glycoprotein Profiling for Colorectal Cancer Biomarker Identification by Lectin Glycoarray and Lectin Blot.
• Plasma Proteome Profiling of a Mouse Model of Breast Cancer Identifies a Set of Up-Regulated Proteins in Common with Human Breast Cancer Cells.
• Molecular markers for predicting prognosis of renal cell carcinoma.
• Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination.
• The unique probe selector: a comprehensive web service for probe design and oligonucleotide arrays.
• Evaluation of Colon Cancer-Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer.
• Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
• Sensitive and Specific New Enzyme-Linked Immunosorbent Assay for N-ERC/Mesothelin Increases its Potential as a Useful Serum Tumor Marker for Mesothelioma.
• Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: U.S. Preventive Services Task Force Recommendation Statement.
• Prognostic value of Tc-99m tetrofosmin myocardial perfusion gated SPECT in patients with diabetes mellitus and suspected coronary artery disease.
• Novel Breast Cancer Biomarkers Identified by Integrative Proteomic and Gene Expression Mapping.
• Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
• Prognostic significance of HIF-2alpha expression on tumor infiltrating macrophages in patients with uterine cervical cancer undergoing radiotherapy.
• Evaluation of the NanoChip 400 System for detection of influenza A and B, respiratory syncytial and parainfluenza viruses.
• Comparison of an in vitro Tuberculosis Interferon-gamma Assay with Delayed-type Hypersensitivity Testing for Detection of Latent Mycobacterium tuberculosis: A Pilot Study in Rheumatoid Arthritis.
• VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value.
• Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
• Electrochemical, Photoelectrochemical, and Piezoelectric Analysis of Tyrosinase Activity by Functionalized Nanoparticles.
• ssDNA Aptamer-Based Surface Plasmon Resonance Biosensor for the Detection of Retinol Binding Protein 4 for the Early Diagnosis of Type 2 Diabetes.
• Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer.
• A new triplex real time-PCR-assay for detection of Mycobacterium avium ssp. paratuberculosis in bovine faeces.
• Mortality in patients with atrial fibrillation has significantly decreased during the last three decades: 35 years of follow-up in 1627 pacemaker patients.
• Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR positive advanced colorectal cancer treated with gefitinib?
• PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer.
• An oligonucleotide microarray for multiplex real-time PCR identification of HIV-1, HBV, and HCV.
• Prognostic Impact of HIF-1alpha Expression in Patients with Definitive Radiotherapy for Cervical Cancer.
• Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.
• Insulin glargine and glulisine SoloSTAR((R)) pens for the treatment of diabetes.
• Labeling, characterization, and in vivo localization of a new (90)Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: Comparison with (99m)Tc-DPD complex.
• Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients With 20-Year Follow-Up.
• Automatic detection and imaging of ischemic changes during electrocardiogram monitoring.
• Sensitive detection of tumor marker CA15-3 in human serum by capillary electrophoretic immunoassay with chemiluminescence detection.
• A Proteomic Analysis of the Plasma Glycoproteins of a MCF-7 Mouse Xenograft: A Model System for the Detection of Tumor Markers.
• Molecular Recognition of Small-Cell Lung Cancer Cells Using Aptamers.
• 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy.
• Cervical cancer screening program integrating Pap smear and HPV DNA testing: A population-based study.
• Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ-labeling and multidimensional liquid chromatography and tandem mass spectrometry.
• COMPARISON of the NUMERICAL and CLINICAL ACCURACY of FOUR CONTINUOUS GLUCOSE MONITORS.
• Detection of amyloid beta protein in the urine of Alzheimer's disease patients and healthy individuals.
• Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease.
• Immunohistochemical Detection of the von Hippel-Lindau Gene Product (pVHL) in Human Tissues and Tumors: A Useful Marker for Metastatic Renal Cell Carcinoma and Clear Cell Carcinoma of the Ovary and Uterus.
• N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.
• Identification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201.
• Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[(11)C]methyl-isoquinoline-5-sulfonamide.
• Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
• Detection and significance of serum protein markers of small-cell lung cancer.
• Evaluation of two anti-hepatitis E virus IgM kits.
• Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
• Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
• In vivo evaluation of the nitroimidazole-based thioflavin-T derivatives as cerebral ischemia markers.
• Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
• Pilot study of transcatheter arterial ethanol embolization under closed renal circuit for large renal cell carcinomas.
• The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
• N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
• (99m)Tc-NC100692 - a tracer for imaging vitronectin receptors associated with angiogenesis: a preclinical investigation.
• Detection of Regional Myocardial Dysfunction in Patients with Acute Myocardial Infarction Using Velocity Vector Imaging.
• Estimated Glomerular Filtration Rate (eGFR) as a Predictor of Outcome after Infrainguinal Bypass in Patients with Critical Limb Ischemia.
• Long-Term Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry).
• A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
• MicroRNAs accurately identify cancer tissue origin.
• SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
• DNA microchips to identify molecular signatures in cervical cancers.
• Prediction of the outcome of preoperative chemotherapy in breast cancer by DNA probes that convey information on both complete and non complete responses.
• DEVELOPMENT AND VALIDATION OF A ONE STEP REAL TIME PCR ASSAY FOR THE SIMULTANEOUS DETECTION OF H5, H7 AND H9 SUBTYPE AVIAN INFLUENZA VIRUSES.
• The Neuropad test: a visual indicator test for human diabetic neuropathy.
• Soluble Intercellular Adhesion Molecule-1 as a Prognostic Marker for Stage II Colorectal Cancer Patients.
• Tribbles-1 as a Novel Biomarker of Chronic Antibody-Mediated Rejection.
• Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis.
• Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
• A remote controlled system for the preparation of 7alpha-[(18)F]fluoro-17alpha-methyl 5alpha-dihydrotestosterone ([(18)F]FMDHT) using microwave.
• Prognostic value of FDG uptake in early stage non-small cell lung cancer.
• Mammography as a Screening Tool for Coronary Artery Disease.
• Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.
• Translational microarray systems for outcome prediction of hepatocellular carcinoma.
• Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
• Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers.
• Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5).
• Assay To Screen for Molecules That Associate with Alzheimer's Related beta-Amyloid Fibrils.
• Economic evaluation of prostate cancer screening with prostate-specific antigen.
• Development and preliminary psychometric testing of a new OA pain measure - an OARSI/OMERACT initiative.
• Detection of early prostate cancer using a hepsin-targeted imaging agent.
• Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study.
• 18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non-Small Cell Lung Cancer.
• Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth.
• Cytomegalovirus DNA Measurement in Blood and Plasma Using Roche LightCycler CMV Quantification Reagents.
• Development and preliminary results of an endoscopic Raman probe for potential in vivo diagnosis of lung cancers.
• Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
• Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
• Functional imaging of neuroendocrine tumors with combined PET/CT using (68)Ga-DOTATATE (DOTA-DPhe(1),Tyr(3)-octreotate) and (18)F-FDG.
• New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
• ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.
• Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
• Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals.
• Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
• Comparison of Coronary Artery Stenting Outcomes in the Eras Before and After the Introduction of Drug-Eluting Stents.
• Utility of a herpes oncolytic virus for the detection of neural invasion by cancer.
• Angioplasty in Critical Limb Ischaemia: One-year Limb Salvage Results.
• Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials.
• Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography ((18)FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC).
• Evaluation of the Loopamp((R)) (loop-mediated isothermal amplification) kit for detecting Norovirus RNA in faecal samples.
• EVALUATION OF THE VERSANT HCV GENOTYPE ASSAY (LiPA) 2.0.
• Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0.
• Non-invasive diagnosis and monitoring of chronic kidney disease by reverse iontophoresis of urea in vivo.
• Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.
• Prospective randomized trial of ACUSEAL (Gore-Tex) vs Finesse (Hemashield) patching during carotid endarterectomy: Long-Term Outcome.
• A rapid recombination assay of HIV-1 using murine CD52 as a novel biomarker.
• Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
• Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-Year results in the CABERNET trial.
• Utilization of an aspiration thrombectomy catheter (Pronto) to treat acute atherothrombotic embolization during percutaneous revascularization of the lower extremity.
• The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.
• Synthesis and Screening of Mono- and Di-Aryl Technetium and Rhenium Metallocarboranes. A New Class of Probes for the Estrogen Receptor.
• Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy.
• A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs.
• 111In-Labeled Galectin-3-Targeting Peptide as a SPECT Agent for Imaging Breast Tumors.
• Disrupted Expression of CXCL5 in Colorectal Cancer Is Associated with Rapid Tumor Formation in Rats and Poor Prognosis in Patients.
• Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target.
• Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer.
• Noninvasive imaging of apoptosis and its application in cancer therapeutics.
• Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.
• Comparison of Efficacy of Low- (80 mg/day) and High- (160-320 mg/day) Dose Valsartan in the Prevention of In-Stent Restenosis after Implantation of Bare-Metal Stents in Type B2/C Coronary Artery Lesions.
• In Vivo Measurement of Vascular Modulation in Experimental Tumors Using a Fluorescent Contrast Agent.
• Various routes of administration of (99m)Tc-labeled synthetic lactoferrin antimicrobial peptide hLF 1-11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice.
• A Rapid Point-of-Care Cardiac Marker Testing Strategy Facilitates the Rapid Diagnosis and Management of Chest Pain Patients in the Emergency Department.
• Detection and Identification of Bacteria in an Isolated System with Near-Infrared Spectroscopy and Multivariate Analysis.
• [(11)C]AZ10419369: A selective 5-HT(1B) receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
• Meta-analysis of Four Randomized Controlled Trials on Long-Term Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Stenting for Multivessel Coronary Artery Disease.
• Meta-analysis of the Effects of Paclitaxel-Eluting Stents Versus Bare Metal Stents on Volumetric Intravascular Ultrasound in Patients With Versus Without Diabetes Mellitus.
• Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
• Monitoring Circulating Tumor Cells in Cancer Vaccine Trials.